Drugs@FDA application timeline
NDA212097
6 dated FDA-coded AP submissions from 2019-09-10 through 2025-03-14, connected to 7 source-defined action assignments and 12 official document links.
6Dated AP submissions
7Action assignments
12Official documents
0Exact enforcement reports
1Reviewed profile mappings
Reviewed identity mapping
Connected peptide profiles
Newest first
Submission and document chronology
6 submissions2025-03-14 · status AP
Supplement 12
FDA action labels
Efficacy-New Indication
2 official documents
- Label ↗2025-03-18 · FDA document 81641
- Letter ↗2025-03-18 · FDA document 81621
2023-12-22 · status AP
Supplement 13
FDA action labels
Labeling-Container/Carton Labels · Labeling-Package Insert · Labeling-Patient Package Insert
2 official documents
- Label ↗2024-01-02 · FDA document 77174
- Letter ↗2023-12-27 · FDA document 77140
2021-08-20 · status AP
Supplement 7
FDA action labels
Labeling-Package Insert
2 official documents
- Letter ↗2021-08-24 · FDA document 68449
- Label ↗2021-08-22 · FDA document 68440
2021-07-15 · status AP
Supplement 8
FDA action labels
Labeling-Package Insert
2 official documents
- Label ↗2021-07-20 · FDA document 68138
- Letter ↗2021-07-19 · FDA document 68112
2020-04-07 · status AP
Supplement 1
FDA action labels
Labeling-Container/Carton Labels
1 official document
2019-09-10 · status AP
Original submission 1
No source action-type assignment was retained for this submission.
3 official documents
- Review ↗2020-02-21 · FDA document 61943
- Label ↗2019-12-18 · FDA document 59952
- Letter ↗2019-09-11 · FDA document 59970
Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.